CLL Society Introduces the Protecting Innovation in Rare Cancers
Por um escritor misterioso
Descrição
/PRNewswire/ -- CLL Society, the world
Cancers, Free Full-Text
The three comprehensive cancer centers that set the model for a
Frontiers Cyclin-dependent kinase inhibitors in malignant
Cancers, Free Full-Text
Cancers, Free Full-Text
Radiotherapy and immunotherapy: open questions and future
CLL Society Inc. (@CllSociety) / X
Cancers, Free Full-Text
Mutational signatures are markers of drug sensitivity of cancer
Rare germline copy number variants (CNVs) and breast cancer risk
Cancers, Free Full-Text
Chemically Defined Antibody– and Small Molecule–Drug Conjugates
de
por adulto (o preço varia de acordo com o tamanho do grupo)